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Abstract
Prioritising candidate genes for further experimental characterisation is a non-trivial challenge in drug discovery and
biomedical research in general. An integrated approach that combines results from multiple data types is best suited for
optimal target selection. We developed TargetMine, a data warehouse for efficient target prioritisation. TargetMine utilises
the InterMine framework, with new data models such as protein-DNA interactions integrated in a novel way. It enables
complicated searches that are difficult to perform with existing tools and it also offers integration of custom annotations
and in-house experimental data. We proposed an objective protocol for target prioritisation using TargetMine and set up a
benchmarking procedure to evaluate its performance. The results show that the protocol can identify known disease-
associated genes with high precision and coverage. A demonstration version of TargetMine is available at http://targetmine.
nibio.go.jp/.
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Introduction
Advances in biomolecular research, coupled with rapidly
increasing availability of information from multiple genome
sequencing initiatives, global gene expression patterns, large scale
molecular interaction experiments and genome wide association
studies, have led to an exponential increase in biological data. The
explosion of data, accompanied by a plethora of theoretical tools
for predicting gene function, has created an information overload.
The immense challenges in separating the biological wheat from
the chaff have necessitated the development of a variety of
analytical tools and databases to store and manage biological data
and retrieve meaningful information to facilitate further experi-
mental characterisation.
The biological role of a gene or a protein is not only defined by
its sequence and structure but also by when and where it is
expressed and its interactions with other biomolecules (such as
proteins, nucleic acids and metabolites). In the post-genomic era,
attempts at function annotation increasingly employ data from
different types of repositories. Biological data from a single type of
data source, though useful, is often limited in extent to which it
may help uncover functional associations; either because of a
systematic bias towards specific genes, gene families and pathways
and/or inclusion of erroneous entries during data acquisition.
With focus shifting from genes and proteins to biological systems,
integrating information from multiple data types is a more robust
and accurate means of enhancing existing interpretations and
unravelling new functional associations as demonstrated in several
studies [1,2].
However, biological data integration is a formidable task.
Different computational tools and data sources may often employ
different approaches and formats for input, storing and retrieving
relevant information that may often result in appreciable differences
in data quality. This heterogeneity often restricts compatibility
between different resources and limits the extent and efficiency of
combined analysis. Furthermore, investigation of diverse data types
necessitates a flexible, uniform and simplified interface to query,
retrieve and analyse data across diverse sources. Despite these
hurdles, the immense potential benefits of a combined investigative
approach have spawned several initiatives towards integrated data
repositories [3,4,5,6,7]. Among these, of particular interest are data
warehouses, which compile all the relevant information to a
common platform [6,8,9,10,11,12,13,14]. A data warehouse is
particularly desirable, since it permits a wide range of queries based
on diverse attributes (including genes, proteins, families, pathways,
ontologies, diseases and expression profiles) and possesses the ability
to produce unifiedoutputand theflexibility inselectingthe type and
the order of the data sources. InterMine is a multi-purpose data
warehouse framework (http://www.intermine.org/), originally
developed for FlyMine, an integrated database for Drosophila and
Anopheles genomics [13]. It features a sequence ontology-based data
model and a user-friendly web interface permitting the end users to
either design flexible and complex database queries, or choose from
a library of‘templates’consistingof predefined querieswith a simple
form and description [13]. In addition, InterMine provides default
parsers for integrating data from several resources with the
framework for incorporating customised parsers and data sources.
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types provides a powerful tool for the researchers. In addition to
FlyMine, InterMine also powers modEncode (http://intermine.
modencode.org/), RatMine (http://ratmine.mcw.edu/ratmine/
begin.do), YeastMine (http://yeastmine.yeastgenome.org:8080/
yeastmine/begin.do) and MetabolicMine (http://www.metabolic
mine.org/).
Identification of suitable targets (such as genes, proteins, non-
peptide gene products and pathways) for characterisation is one of
the most critical steps in biology, particularly in annotating gene
function, drug discovery and understanding molecular bases of
diseases. An integrated approach that combines results from
multiple data types is best suited for optimal target discovery
[15,16]. The distinct merits of the InterMine framework have
inspired us to develop TargetMine, an integrated resource for
retrieval of target genes and proteins for experimental character-
isation and drug discovery. In this paper, we describe the data
sources available in the present release of TargetMine and their
access and query capability. We also outline an objective protocol
for target prioritisation with TargetMine that relies on the
integration of diverse data types. Gene prioritisation refers to the
selection of most interesting or promising genes from a larger set of
genes for further analysis [17,18]. Experimental evaluation of large
gene lists to identify suitable candidates is a formidable and often
impossible task and therefore, computational tools for candidate
gene prioritisation have emerged over the years. These tools
variously rely on functional associations, protein-protein interac-
tions, gene expression data, sequence and structure properties or
combinations thereof to select candidate genes [16,17,18,19,
20,21,22,23,24,25]. TargetMine was designed specifically for
target prioritisation within the framework of a data warehouse
and our prioritisation protocol, though less sophisticated than
some standalone tools, is easier to use and provides flexibility in the
choice of data sources that may be employed for analysis of query
gene sets. Finally, we discuss the possibilities of future implemen-
tations in the TargetMine data warehouse to provide maximum
coverage of the biological target space.
Results and Discussion
Data sources and Data models
A detailed description of the InterMine system is available
elsewhere [13]. Here we restrict ourselves to a brief overview of the
InterMine data organisation. InterMine is an open source data
warehouse framework. Each entry in the system (such as a gene or
a protein) is considered an ‘object’. The InterMine object-based
data model, consists of ‘classes’ and reflects the relationships
between different data types. Each class contains objects that share
similar properties and a set of ‘attributes’ that correspond to
various types of information (such as gene symbol and gene/
protein identifier) associated with each object of that class. The
classes are linked with each other by references that specify the
associations between objects in different classes. The InterMine
data structure readily allows the navigation of the stored biological
data via the relationships between different data types, facilitated
by an inbuilt tool termed ‘query builder’. The query builder tool
permits the users to select and constrain the data types for the
desired output. The list function enables the query process to be
performed with a user-supplied list of objects and export the lists as
either comma separated (csv) or tab separated values (tsv). It also
permits the user to convert genes/proteins from one species to
another based on KEGG orthology associations. The InterMine
Web Service allows the users to query TargetMine from their own
web pages and applications.
In addition to the existing InterMine classes, we have
customised the InterMine data model and created new classes to
collate biological data types most likely to help facilitate target
discovery (Table S1). We will discuss some of these implementa-
tions below. As of now, the biological data in TargetMine for most
part is limited to human, rat, mouse and fruit fly, the best studied
model organisms in biology. The data sources compiled in
TargetMine are summarised in Table 1.
Protein structures and domains
Structural data for biological macromolecules, especially
proteins, have been extremely important in explaining their
molecular and biochemical functions, evolutionary relationships
and understanding their explicit biological roles [26]. It is well
recognised that complementing protein sequence information with
structural data is a robust approach towards more accurate protein
function annotation [27] and hence, more reliable target
discovery. However, integrating protein sequence and structural
information from different sources remains a non-trivial task. In
recognition of the obvious benefits of an integrated protein
sequence-structure repository, we customised and embellished the
default InterMine data model to combine protein sequence
information from the UniProt database [28] with protein structure
information from the Protein Data Bank (PDB) [29] and structural
classification based on evolutionary relationships in the Structural
Classification of Proteins (SCOP) database [30]. With our
customised data model, the user can easily query for PDB
structures cross-referenced (if available) with the protein of interest
in the UniProt repository and other databases such as DrugBank
[31] (e.g., ‘‘Show all the protein structures that contain the targets,
as defined in DrugBank, of a given set of drugs’’ or ‘‘Given a list of
Table 1. List of data sources in TargetMine.
Data Organism* Source
InterMine default
Genome annotation H, R, M, F Entrez Gene
Protein annotation H, R, M, F UniProtKB
Protein domain H, R, M InterPro
Pathways H, R, M, F KEGG Pathway
Gene-gene interactions H, R, M, F BioGRID
GO annotation and the Gene
Ontology
H, R, M Gene Ontology,
UniProtKB GOA
Data sources newly incorporated in TargetMine
Protein 3D structure Entire dataset PDBe SIFTS
Protein-protein interactions H PPIview
Protein domain annotations H, R, M IPI
Structural classification Entire dataset SCOP
Orthologues / Paralogues H, R, M, F, E KEGG Orthology
Transcription factor H OregAnno, AMADEUS
Enzyme H, R, M, F The ENZYME database
Drug H DrugBank
Disease H OMIM{
Disease Ontology and DO
annotation
H Disease Ontology, BMC
Genomics 10 Suppl 1:S6
*H: human, R: rat, M: mouse, F: fruit fly (Drosophila), E: E. coli.
{OMIM data are presently not distributed with the TargetMine demonstration
version.
doi:10.1371/journal.pone.0017844.t001
TargetMine Data Warehouse for Target Discovery
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structure of these proteins if present’’). The user can also retrieve
disease associations, pathway associations and potential protein-
drug associations, based on ligands associated with the protein
structures, for the protein of interest (e.g., ‘‘Show all the PDB
entries that contain a given drug’’).
Different data sources use different numbering systems for
specifying protein regions. To associate protein sequences (in the
Protein class) with protein structures (in the ProteinStructure class),
we introduced two new classes (ProteinStructureRegion and
PDBRegion; Figure 1). We also introduced the ProteinDomain-
Region class to link the Protein class to the Protein domain class
that stores InterPro [32] domain annotations. The PDB-UniProt
mapping was taken from SIFTS [33] and InterPro domain
assignments from IPI [34]. The integration facilitated querying
detailed domain and structural assignments; for example, the user
can query regions of a protein, for which structural information is
available, and then retrieve domain annotations falling within
these regions.
Transcription factors
Transcription factors (TFs) are proteins that bind to specific
DNA sequences, thereby regulating the expression (transcription)
of their target genes [35]. TFs are of immense significance in
biomedical investigations and some TFs such as nuclear receptors
are important drug targets [36,37]. In view of the significance of
these protein-DNA interactions to cellular physiology, we modified
the existing InterMine Interaction class, which describes gene-gene
interactions, to define a new class named ProteinDNAInteraction.
The ProteinDNAInteraction class contains specific attributes that
reflect the unique aspects of protein-DNA interactions, such as
protein (TF) binding sites in the regulatory regions of the target
genes. These data were retrieved from AMADEUS [38] and
OregAnno [39] resources and from assorted literature sources.
Since different resources adopt different approaches to compiling
protein-DNA interaction information, the combined source data
were manually processed to uniformly assign Entrez gene
identifiers to each participating gene and remove redundancies
prior to the incorporation into TargetMine. The integration
enabled us to make a complicated query such as: ‘‘Given a list of
genes, retrieve all the TF-target relations observed within the list’’.
Other data classes
For disease and phenotype association, we created new classes
and data parsers to retrieve the data from OMIM database [40]
and human genome disease annotations [41]. Enzymes play key
roles in many biological processes and are attractive candidates for
experimental investigation aimed at understanding cellular
Figure 1. Schema for selected examples of newly created data sources in TargetMine. The data model is depicted as a class diagram in the
Unified Modeling Language (http://www.uml.org). Some details of the model are ignored to reduce the complexity of the diagram.
doi:10.1371/journal.pone.0017844.g001
TargetMine Data Warehouse for Target Discovery
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designed a new Enzyme class (linked to the Protein class) to gather
all information on enzymes as curated in the Enzyme database
[42]. The Enzyme class was also directly linked to the Pathway
class by parsing the KEGG [43] mapping files, thereby providing
links to their potential roles in cellular processes. Most genes and
proteins function in association with other proteins and thus, the
study of protein-protein interactions (PPIs) is critical to under-
standing their roles in living systems. In addition to the default
InterMine Interaction class that was employed for storing
biomolecular interactions from the BioGRID database [44], we
designed a new ProteinInteraction class to collate all interactions
curated in PPIview, an integrated repository of human PPIs [45].
This integration facilitated the querying of interacting partners of a
gene/protein or a list of genes/proteins of interest and infer overall
interaction networks involving these genes/proteins.
In addition, to expand the information space for sparsely
annotated genes and proteins, we provided a framework for
including in silico annotations derived from selected protein
prediction tools (FUGUE [46], Protein-DNA binding propensity
[47] and Protein-protein interaction sites [48]) and for including
experimental data from in-house research.
Target prioritisation and benchmarking
Our general protocol for target prioritisation using TargetMine
is shown in Figure 2. First, we upload a list of initial candidate
genes or proteins (e.g., a set of differentially expressed genes or a
set of proteins that interact with a given protein) to TargetMine to
create a TargetMine gene list. Enrichment of specific biological
themes (including but not limited to, KEGG pathways, Gene
Ontology (GO) terms [49] and OMIM phenotypes) associated
with the initial list is estimated by hypergeometric distribution and
the inferred p-values are further adjusted for multiple test
corrections to control the false discovery rate using the Benajmini
and Hochberg procedure [50]. The significantly enriched
biological associations (that satisfied, in this instance, a condition
of p#0.05 after a multiple test correction with the Benajmini and
Hochberg procedure) can be visualised in the individual
enrichment widgets. We gather the genes mapped to the top N
significant associations (where N=1,2,3…, an adjustable value
reflecting incrementally relaxed thresholds) retrieved from KEGG
(A), GO Biological Process (B) and OMIM (C) databases into
separate lists and merge them (for example, by taking the union
A|B|C of the retrieved genes) to infer corresponding sets of
prioritised genes, albeit no ranking is provided at the moment. (We
assume that an initial candidate list is from a single species and the
enrichment calculation is performed using the data for this species
only.)
To evaluate the effectiveness of TargetMine in identifying
suitable targets for further characterisation, we performed target
gene prioritisation tests (as described above) on 19 sets of known
disease-associated genes compiled from the literature [51] (Table 2
and Figures 3 and 4; see Materials and Methods for details). In all
instances, our prioritisation approach was supported by high
sensitivity and precision values, and enforcing a threshold of
collecting only the genes mapped to top seven associations (that
satisfied a p-value cutoff of p#0.05 after a multiple test correction
with the Benajmini and Hochberg procedure) was by and large
most suited to ensuring maximum coverage and minimum over-
prediction (Table S2). Though for cirrhosis and cervical carcinoma,
the number of false positives was slightly larger than those for the
other diseases, the sensitivity and precision remained high.
We have repeated the tests by changing the proportion of
known curated genes in an input gene list (from one third to one
tenth). Although both sensitivity and precision decreased slightly,
reasonable performance was maintained with a cutoff of six (Table
S3), suggesting that the method still works for situations where only
one tenth of input genes are disease-associated. We have also
evaluated the results from a method using only a single data
source. By taking the union of the collected genes from KEGG,
GO and OMIM, the performance in most cases increased by
about 0.1 points (measured by the F-score; see Materials and
Methods), demonstrating the usefulness of the integration.
These results showed that the integration of diverse biological
properties in TargetMine was a successful approach towards the
identification of candidate genes for further investigation. Besides,
the operation in TargetMine is semi-automatically accomplished
by a few mouse clicks instead of preparing specific data files and
running external software. The TargetMine data model permits
retrieval of stored data and its analysis in a single interface and
thus aids in efficient prioritisation. The ease of accomplishing such
analysis via a simple web interface further underscores the utility of
TargetMine as an effective tool in investigation of genes and
genomes. In our benchmark tests, we chose KEGG, GO
Biological Process and OMIM as the best sources for highlighting
the functional associations of groups of genes but TargetMine also
provides enrichment widgets for GO Molecular Function and
Cellular Component, Drug and Disease Ontology (DO) associa-
tions, which may be used to assist in selecting candidate genes.
The user may also employ TF-target associations to identify
common regulatory themes that may be associated with a set of co-
expressed functionally similar genes.
Comparisons with other databases
As a data warehouse, TargetMine is not an alternative to large
public databases (such as UniProt [28]) but rather, it is designed
for use in individual laboratories in academia and industry. In
comparison to existing integrated databases, TargetMine provides
an alternative usage that aims to rapidly and efficiently retrieve
varied biological information for large gene sets in a simplified
manner. Most integrated databases are able to retrieve different
biological properties, but are largely designed for simple queries
for a single gene. Though some may provide facilities for batch
query, the users in many instances need to employ external scripts
for querying and post-processing the relevant data. In contrast,
TargetMine provides a simple interface for batch query with
numerous templates and the facility to construct complicated
queries. The output options permit user-defined displays on the
type and the order of different annotations. Besides, the
enrichment widgets, as described above, provide a quick
preliminary analysis of the genes in the list and thus, greatly help
in understanding the enriched themes associated with query sets
and also help complement the analysis performed by specialised
gene prioritisation tools. Therefore, TargetMine facilitates biolog-
ical data gathering and data analysis in a single user-friendly
interface.
Although some commercial resources such as IngenuityH
(Redwood City, California) and MetaCore
TM (GeneGo, St.
Joseph, MI) provide more interaction and/or pathway data plus
tools for statistical data analysis, they largely emphasise on
collating gene annotations and mostly lack protein level
Figure 2. A schematic representation of the suggested objective protocol for candidate gene prioritisation with TargetMine.
doi:10.1371/journal.pone.0017844.g002
TargetMine Data Warehouse for Target Discovery
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data types available in TargetMine such as Protein-DNA
interactions, to the best of our knowledge, are not made
available by other publicly available resources, some of which,
including GeneDistiller [52] and PolySearch [53], can perform
tasks similar to TargetMine’s. However, the key difference is
TargetMine’s flexibility and its built-in prioritisation protocol;
the data size and data types are readily customisable in
TargetMine, providing a more flexible and comprehensive
framework for target discovery.
TargetMine employs an ‘‘unsupervised’’ protocol for prioritisation,
as opposed to most other comparable tools such as ToppGene [21]
and Endeavour [20], which are ‘‘supervised’’ learning methods.
Thus, while direct comparison with these other tools is difficult (and
our data warehouse will complement, not replace, stand-alone tools),
the preliminary results above suggest that TargetMine is well suited
for target prioritisation. In our group, we have been using
TargetMine for analysing a diverse array of experimental data and
we have verified experimentally that some of the prioritised genes
have been associated with the disease of interest [54].
Future developments
TargetMine is structured to accommodate increasingly avail-
able biological data from large-scale experiments. Inclusion of new
data sources would enable enhanced repertoire of functional
associations currently available in TargetMine and at the same
time expand the coverage to newer systems relevant to candidate
gene prioritisation and drug discovery. We plan to add new data
including host-pathogen interactions, specific gene and protein
expression patterns, relationships between potential targets and
chemical compounds and/or moieties, protein-compound inter-
actions and single nucleotide polymorphisms (SNPs). We aim to
supplement the newer data sources with further developments in
the TargetMine web interface, lists, templates and tools for data
visualisation (such as novel widgets) and analysis.
Conclusion
TargetMine is an integrated data warehouse that enables
complicated searches that are difficult to perform using existing
comparable tools and therefore, assists in efficient target
Table 2. Benchmarking results for 19 sets of known disease-
associated genes using top seven significant associations as
the threshold.
Disease Sensitivity Precision F-score
Atherosclerosis (athe) 0.78660.04 0.84860.06 0.81460.03
Autism (auti) 0.82460.02 0.83960.07 0.83060.03
Cervical carcinoma (cerv) 0.77960.03 0.83460.03 0.80560.03
Cirrhosis (cirr) 0.85060.02 0.84860.05 0.84860.02
Endometrial carcinoma (enca) 0.77060.02 0.90360.06 0.82960.02
Endometriosis (endo) 0.62160.07 0.89760.07 0.72960.03
Epilepsy (epil) 0.74460.02 0.77760.08 0.75960.03
Grave’s disease (grav) 0.80360.01 0.93460.04 0.86360.02
Hypercholesterolaemia (hycl) 0.87560.00 0.89360.03 0.88460.02
Inflammatory bowel disease
(inbd)
0.89760.04 0.83860.08 0.86360.04
Ischaemic stroke (isch) 0.90960.04 0.84560.08 0.87460.04
Lymphoma (lymp) 0.63660.10 0.78860.06 0.69760.05
Migraine (migr) 0.71260.03 0.81260.10 0.75560.03
Myocardial ischemia (myis) 0.80360.02 0.88960.06 0.84260.03
Neural tube defects (neur) 0.68260.03 0.81760.07 0.74260.03
Osteoarthritis (oste) 0.82260.02 0.87060.05 0.84460.02
Pancreatitis (panc) 0.92360.05 0.87460.07 0.89560.03
Systemic scleroderma (sysc) 0.82660.03 0.81860.06 0.82160.03
Ulcerative colitis (ulco) 0.85660.02 0.83160.08 0.84160.04
doi:10.1371/journal.pone.0017844.t002
Figure 3. Outline of the procedure for benchmarking candidate gene prioritisation on 19 sets of known disease-associated genes
with TargetMine. TP- True positive, FP- False positive (see text for details).
doi:10.1371/journal.pone.0017844.g003
TargetMine Data Warehouse for Target Discovery
PLoS ONE | www.plosone.org 6 March 2011 | Volume 6 | Issue 3 | e17844prioritisation. The benchmarking results for our proposed protocol
for target gene prioritisation suggested the effectiveness of
TargetMine in target discovery. The flexibility in TargetMine
structure ensures that different types of biological data can be
readily added and analysed to generate new hypotheses for further
investigation. The inclusion of additional data sources and
analytical tools will greatly enhance the ability of TargetMine to
investigate biological systems for better target discovery.
Materials and Methods
InterMine was downloaded from http://www.intermine.org.
New parsers were written in Java and integrated into the
InterMine code base. A list of URLs for the individual data
sources can be found in Table S4. Part of OMIM data, not
available in downloadable files, was retrieved from the online
resource using custom PERL scripts and TF-target associations
were manually processed prior to integration into TargetMine.
To benchmark our gene prioritisation protocol, we performed
target gene prioritisation on 19 sets of known disease-associated
genes (denoted by set x) compiled from the literature [51]. We first
created test datasets (set y), where each curated gene set was
merged with twice its number of unrelated randomly selected
human genes (set r) to incorporate background ‘‘noise’’. To avoid
any bias incurred due to the selection of random genes, the process
was repeated 10 times to infer 10 test gene sets for each curated
gene list. The prioritisation tests (Figures 2 and 3) were then
performed for each test gene set. We gathered the genes mapped
to up to the top 10 associations, retrieved from KEGG, GO and
OMIM databases to infer prioritised genes (set z). These were then
compared with the curated gene sets (x>z) and the efficiency of the
prioritisation procedure was estimated with sensitivity and
precision measures (Table S2). The True Positives (TP)i nz were
defined as genes present in x, while those corresponding to r were
defined as False Positives (FP). The False Negatives (FN) were those
genes corresponding to x that were not included in z at the
specified threshold, while the True Negatives (TN) were genes
corresponding to r correctly left out from the list of prioritised
genes at a given threshold. Sensitivity, measuring the proportion of
the known disease-associated genes that were correctly prioritised,
was defined as TP/(TP+FN) and precision, measuring the
proportion of the prioritised genes that were known disease-
associated genes, was defined as TP/(TP+FP). The performance of
the prioritisation protocol was also assessed using the F-score
defined as 2(precision6sensitivity)/(precision+sensitivity) [55,56].
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Table S1 A full list of newly defined classes in TargetMine.
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Table S2 Detailed benchmarking results for candidate gene
prioritisation with TargetMine using 19 sets of known disease-
associated genes.
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Table S3 Detailed benchmarking results for candidate gene
prioritisation with TargetMine using 19 sets of known disease-
associated genes with increased background noise.
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Acknowledgments
We thank Mitsubishi Space Software Co., Ltd. for technical support. We
gratefully acknowledge Dr. Tadashi Imanishi of Biomedicinal Information
Figure 4. Benchmarking results for 19 sets of known disease-associated genes. (The full disease names and their abbreviations are listed in
Table 2.) Each line represents the F-score for a particular disease data set as a function of the threshold (the top N significant associations considered).
The error bars show the standard deviation across ten benchmarking evaluations for each disease.
doi:10.1371/journal.pone.0017844.g004
TargetMine Data Warehouse for Target Discovery
PLoS ONE | www.plosone.org 7 March 2011 | Volume 6 | Issue 3 | e17844Research Centre (AIST) for providing us with the PPIview interactions and
permission for publishing the data.
Author Contributions
Conceived and designed the experiments: YAC LPT KM. Performed the
experiments: YAC LPT KM. Analyzed the data: YAC LPT KM.
Contributed reagents/materials/analysis tools: YAC LPT KM. Wrote
the paper: YAC LPT KM. Conceived and directed the project: KM.
Designed the data warehouse and analyzed data: YAC, LPT and KM.
Developed software: YAC.
References
1. Ge H, Walhout AJ, Vidal M (2003) Integrating ‘omic’ information: a bridge
between genomics and systems biology. Trends Genet 19: 551–560.
2. Gerstein M, Lan N, Jansen R (2002) Proteomics. Integrating interactomes.
Science 295: 284–287.
3. Burgun A, Bodenreider O (2008) Accessing and integrating data and knowledge
for biomedical research. Yearb Med Inform. pp 91–101.
4. Chen LS, Emmert-Streib F, Storey JD (2007) Harnessing naturally randomized
transcription to infer regulatory relationships among genes. Genome Biol 8:
R219.
5. Garcia Castro A, Chen YP, Ragan MA (2005) Information integration in
molecular bioscience. Appl Bioinformatics 4: 157–173.
6. Stein LD (2003) Integrating biological databases. Nat Rev Genet 4: 337–345.
7. Wong L (2002) Technologies for integrating biological data. Brief Bioinform 3:
389–404.
8. Birkland A, Yona G (2006) BIOZON: a system for unification, management and
analysis of heterogeneous biological data. BMC Bioinformatics 7: 70.
9. Cornell M, Paton NW, Hedeler C, Kirby P, Delneri D, et al. (2003) GIMS: an
integrated data storage and analysis environment for genomic and functional
data. Yeast 20: 1291–1306.
10. Helfrich JP (2002) Raw data to knowledge warehouse in proteomic-based drug
discovery: a scientific data management issue. Biotechniques Suppl: 48–50,
52–43.
11. Kasprzyk A, Keefe D, Smedley D, London D, Spooner W, et al. (2004)
EnsMart: a generic system for fast and flexible access to biological data. Genome
Res 14: 160–169.
12. Lee TJ, Pouliot Y, Wagner V, Gupta P, Stringer-Calvert DW, et al. (2006)
BioWarehouse: a bioinformatics database warehouse toolkit. BMC Bioinfor-
matics 7: 170.
13. Lyne R, Smith R, Rutherford K, Wakeling M, Varley A, et al. (2007) FlyMine:
an integrated database for Drosophila and Anopheles genomics. Genome Biol 8:
R129.
14. Shah SP, Huang Y, Xu T, Yuen MM, Ling J, et al. (2005) Atlas - a data
warehouse for integrative bioinformatics. BMC Bioinformatics 6: 34.
15. Chen X, Jorgenson E, Cheung ST (2009) New tools for functional genomic
analysis. Drug Discov Today 14: 754–760.
16. Yang Y, Adelstein SJ, Kassis AI (2009) Target discovery from data mining
approaches. Drug Discov Today 14: 147–154.
17. Nitsch D, Goncalves JP, Ojeda F, de Moor B, Moreau Y (2010) Candidate gene
prioritization by network analysis of differential expression using machine
learning approaches. BMC Bioinformatics 11: 460.
18. Tranchevent Lo-C, Capdevila FB, Nitsch D, De Moor B, De Causmaecker P,
et al. (2010) A guide to web tools to prioritize candidate genes. Briefings in
Bioinformatics.
19. Adie EA, Adams RR, Evans KL, Porteous DJ, Pickard BS (2006) SUSPECTS:
enabling fast and effective prioritization of positional candidates. Bioinformatics
22: 773–774.
20. Aerts S, Lambrechts D, Maity S, Van Loo P, Coessens B, et al. (2006) Gene
prioritization through genomic data fusion. Nat Biotechnol 24: 537–544.
21. Chen J, Bardes EE, Aronow BJ, Jegga AG (2009) ToppGene Suite for gene list
enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37:
W305–311.
22. Hutz JE, Kraja AT, McLeod HL, Province MA (2008) CANDID: a flexible
method for prioritizing candidate genes for complex human traits. Genet
Epidemiol 32: 779–790.
23. Kohler S, Bauer S, Horn D, Robinson PN (2008) Walking the interactome for
prioritization of candidate disease genes. Am J Hum Genet 82: 949–958.
24. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, et al. (2007) A
human phenome-interactome network of protein complexes implicated in
genetic disorders. Nat Biotechnol 25: 309–316.
25. Perez-Iratxeta C, Wjst M, Bork P, Andrade MA (2005) G2D: a tool for mining
genes associated with disease. BMC Genet 6: 45.
26. Joachimiak A (2009) High-throughput crystallography for structural genomics.
Curr Opin Struct Biol 19: 573–584.
27. Watson JD, Laskowski RA, Thornton JM (2005) Predicting protein function
from sequence and structural data. Curr Opin Struct Biol 15: 275–284.
28. The UniProt Consortium (2010) The Universal Protein Resource (UniProt) in
2010. Nucleic Acids Res 38: D142–148.
29. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The
Protein Data Bank. Nucleic Acids Res 28: 235–242.
30. Murzin AG, Brenner SE, Hubbard T, Chothia C (1995) SCOP: a structural
classification of proteins database for the investigation of sequences and
structures. J Mol Biol 247: 536–540.
31. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank:
a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36:
D901–906.
32. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, et al. (2009)
InterPro: the integrative protein signature database. Nucleic Acids Res 37:
D211–215.
33. Velankar S, McNeil P, Mittard-Runte V, Suarez A, Barrell D, et al. (2005) E-
MSD: an integrated data resource for bioinformatics. Nucleic Acids Res 33:
D262–265.
34. Kersey PJ, Duarte J, Williams A, Karavidopoulou Y, Birney E, et al. (2004) The
International Protein Index: an integrated database for proteomics experiments.
Proteomics 4: 1985–1988.
35. Latchman DS (1997) Transcription factors: an overview. Int J Biochem Cell Biol
29: 1305–1312.
36. Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are
there? Nat Rev Drug Discov 5: 993–996.
37. Nebert DW (2002) Transcription factors and cancer: an overview. Toxicology
181–182: 131–141.
38. Linhart C, Halperin Y, Shamir R (2008) Transcription factor and microRNA
motif discovery: the Amadeus platform and a compendium of metazoan target
sets. Genome Res 18: 1180–1189.
39. Griffith OL, Montgomery SB, Bernier B, Chu B, Kasaian K, et al. (2008)
ORegAnno: an open-access community-driven resource for regulatory annota-
tion. Nucleic Acids Res 36: D107–113.
40. McKusick-Nathans Institute of Genetic Medicine JHUB, MD) and National
Center for Biotechnology Information, National Library of Medicine (Bethesda,
MD) (2010) Online Mendelian Inheritance in Man, OMIM (TM).
41. Osborne JD, Flatow J, Holko M, Lin SM, Kibbe WA, et al. (2009) Annotating
the human genome with Disease Ontology. BMC Genomics 10 Suppl 1: S6.
42. Bairoch A (2000) The ENZYME database in 2000. Nucleic Acids Res 28:
304–305.
43. Aoki-Kinoshita KF, Kanehisa M (2007) Gene annotation and pathway mapping
in KEGG. Methods Mol Biol 396: 71–91.
44. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, et al. (2006)
BioGRID: a general repository for interaction datasets. Nucleic Acids Res 34:
D535–539.
45. Yamasaki C, Murakami K, Fujii Y, Sato Y, Harada E, et al. (2008) The H-
Invitational Database (H-InvDB), a comprehensive annotation resource for
human genes and transcripts. Nucleic Acids Res 36: D793–799.
46. Shi J, Blundell TL, Mizuguchi K (2001) FUGUE: sequence-structure homology
recognition using environment-specific substitution tables and structure-
dependent gap penalties. J Mol Biol 310: 243–257.
47. Ahmad S, Gromiha MM, Sarai A (2004) Analysis and prediction of DNA-
binding proteins and their binding residues based on composition, sequence and
structural information. Bioinformatics 20: 477–486.
48. Murakami Y, Mizuguchi K (2010) Applying the Naive Bayes classifier with
kernel density estimation to the prediction of protein-protein interaction sites.
Bioinformatics 26: 1841–1848.
49. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene
ontology: tool for the unification of biology. The Gene Ontology Consortium.
Nat Genet 25: 25–29.
50. Noble WS (2009) How does multiple testing correction work? Nat Biotechnol 27:
1135–1137.
51. Chen J, Xu H, Aronow BJ, Jegga AG (2007) Improved human disease candidate
gene prioritization using mouse phenotype. BMC Bioinformatics 8: 392.
52. Seelow D, Schwarz JM, Schuelke M (2008) GeneDistiller–distilling candidate
genes from linkage intervals. PLoS One 3: e3874.
53. Cheng D, Knox C, Young N, Stothard P, Damaraju S, et al. (2008) PolySearch:
a web-based text mining system for extracting relationships between human
diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res 36:
W399–405.
54. Tripathi LP, Kataoka C, Taguwa S, Moriishi K, Mori Y, et al. (2010) Network
based analysis of hepatitis C virus Core and NS4B protein interactions. Mol
Biosyst 6: 2539–2553.
55. Hripcsak G, Rothschild AS (2005) Agreement, the f-measure, and reliability in
information retrieval. J Am Med Inform Assoc 12: 296–298.
56. van Rijsbergen CJ (1979) Information retrieval. London: Butterworths.
TargetMine Data Warehouse for Target Discovery
PLoS ONE | www.plosone.org 8 March 2011 | Volume 6 | Issue 3 | e17844